Clinical Trials Access Collaborative

Committed to making medical research more accessible.

CTAC builds on the lessons of its planning grant and learning phase, Equitable Breakthroughs in Medicine Development. CTAC strives to ensure those who wish to participate in clinical trials have the opportunity to do so. We connect clinical trial sponsors, healthcare institutions, community organizations, and the broader research ecosystem to accelerate participation and strengthen research capacity in communities across the country.

We believe expanding access to clinical trials and medical innovation is essential to improving science and developing better therapeutics that truly change health outcomes.

Improving access across all communities and zip codes can strengthen health for generations to come, unlock economic mobility through workforce development, and reinforce U.S. leadership in clinical research.

The Network Partners

CTAC is led by national clinical research experts. Our Network Partners continue to provide valuable advisory support and mentorship to sites as they build sustainable research capacity. They include the Yale School of Medicine, Morehouse School of Medicine, the Research Centers in Minority Institutions Coordinating Center (RCMI-CC) at Morehouse School of Medicine, and Vanderbilt University Medical Center.

CTAC Website Partners

Key elements for making local sites sustainable in the clinical trial ecosystem include:

Building on existing strengths and capabilities using a co-developed maturity model

Developing lasting partnerships.

Providing continuous mentoring support from CTAC Network Partners to help sites meet their goals and aspirations

Pharmaceutical Research and Manufacturers of America (PhRMA) awarded a $10 million grant to Yale University to support the creation and development of this initiative. PhRMA convened thousands of stakeholders in the process to design this learning phase to work with 10 sites in underserved communities to help enhance diverse participation in clinical trials and uncover learnings to promote sustainability and success.

PhRMA logo

* CTAC is a tax‑exempt nonprofit organization under section 501(c)(3) of the Internal Revenue Code.

The Learning Phase includes:

  • Connecting Clinical Trial Sponsors: Bringing sponsors and local EQBMED-selected sites together to work as partners.
  • Sharing Key Learnings: Sharing important lessons learned from these partnerships.
  • Building Robust Infrastructure: Creating a strong support system that continues to support the growth and aspirations of local sites.